NEURONAX is a privately-held biotech company focusing on the development of candidate-drugs for the treatment of traumatic or severe degenerative disorders of the central nervous system (CNS).
NEURONAX focuses particular nervous disorders for which the capacities to treat patients are limited and the "unmet needs" are very important. Among them, injuries of the CNS are among the major clinical problems since the consequences are currently irreversible resulting in serious disabilities in sensory and motor function.
Our most advanced product candidate, NX210, a neuro-protective and neuro-regenerative peptide, was deduced from a naturally secreted protein produced early during emryonic development by specialized ependymal cells located in the brain. This promising first-in-class candidate has been shown to improve recovery and neurological function and may adress treatment of various acute and chronic disorders, including but not limited to spinal cord injuries (SCI), traumatic brain injuries (TBI), stroke, Alzheimer or Parkinson’s diseases.
For more information, please visit our website.
Company Details
- Founded
- -
- Address
- 60 Avenue Rockefeller, Lyon,69008,france
- Phone
- 33473178389
- co****@****nax.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- neuronax.com
- Keywords
- neural repair, neuroprotection, spinal cord injury, neurodegenerative diseases, candidate-drug, preclinical, neuroregeneration, peptide, traumatic brain injury, stem cells, axon outgrowth.
- HQ
- Lyon
Neuronax (Now Axoltis Pharma) Questions
Neuronax (Now Axoltis Pharma)'s helpline number is 33473178389
Neuronax (Now Axoltis Pharma)'s website is neuronax.com
Neuronax (Now Axoltis Pharma)'s LinkedIn profile is https://fr.linkedin.com/company/neuronax-sas
Neuronax (Now Axoltis Pharma)'s industry is
Pharmaceutical Manufacturing
Neuronax (Now Axoltis Pharma)'s top competitors are
Macopharma,
Axoltis Pharma,
Enyo Pharma,
Novadiscovery, The Effect Model Company,
Advanced Biodesign,
Inovactis,
Brenus Pharma,
Crcl Centre De Recherche En Cancérologie De Lyon,
Phaxiam Therapeutics,
Stromacare.
Neuronax (Now Axoltis Pharma)'s support email address is contact@neuronax.com
Neuronax (Now Axoltis Pharma)'s categories are Pharmaceutical Manufacturing
Neuronax (Now Axoltis Pharma)'s founding year is 2003
